REFERENCES
- Blumberg , H. , Dayton , H. B. and Wolf , P S. 1966 . “Counteraction of Narcotic Antagonist Analgesics by the Narcotic Antagonist Naloxone.” . Proc. Soc. Exp. Biol. Med. , Vol. 123 : 755 – 758 .
- Cherubin , C. E. 1967 . “The Medical Sequelae of Narcotic Addiction.” . Ann. Intern. Med. , Vol. 67 July : 23 – 33 .
- Dole , V. P. and Nyswander , M. 1965 . “A Medical Treatment for Diacetylmorphine (Heroin) Addiction.” . J.A.M.A. , Vol. 193 23 August : 646 – 650 .
- Fink , M. and Freedman , A. M. 1970 . “Antagonists in the Treatment of Opiate Dependence.”. ” . In Modern Trends in Drug Dependence and Alcoholism. Edited by: Phillipson , R. V. 49 – 59 . London : Butterworth. .
- Fink , M. , Freedman , A. M. , Zaks , A. , Sharoff , R. L. and Resnick , R. 1969 . “Narcotic Antagonists and Substitutes in Opiate Dependence.”. ” . In The Present Status of Psychotropic Drugs. Edited by: Cerletti , A. and Bove , F. J. 428 – 431 . Amsterdam : Excerpta Medica. .
- Fink , M. , Zaks , A. , Sharoff , R. , Mora , A. , Bruner , A. , Levit , S. and Freedman , A. M. 1968 . “Naloxone in Heroin Dependence.” . Clin. Pharmacol. Ther. , Vol. 9 September-October : 568 – 577 .
- Foldes , F. F. , Lunn , J. , Moore , J. and Brown , I. 1963 . “N-allyl-noroxymorphone: A New Potent Narcotic Antagonist.” . Amer. J. Med. Sci. , Vol. 245 : 23 – 30 .
- Freedman , A. M. , Fink , M. , Sharoff , R. and Zaks , A. 1967 . “Cyclazocine and Methadone in Narcotic Addiction.” . J.A.M.A. , Vol. 202 : 191 – 194 .
- Freedman , A. M. , Fink , M. , Sharoff , R. and Zaks , A. 1968 . “Clinical Studies of Cyclazocine in the Treatment of Narcotic Addiction.” . Amer. J. Psychiat. , Vol. 124 May : 1499 – 1504 .
- Gorodetzky , C. W. , Sapira , J. D. , Jasinski , D. R. and Martin , W. R. 1968 . “Liver Disease in Narcotic Addicts.” . Clin. Pharmacol. Ther. , Vol. 9 : 720 – 739 .
- Jaffe , J. H. and Brill , L. 1966 . “Cyclazocine, a Long Acting Narcotic Antagonist: Its Voluntary Acceptance as a Treatment Modality by Narcotic Abusers.” . Int. J. Addict. , Vol. 1 January : 99 – 123 .
- Jasinski , D. R. , Martin , W. R. and Haertzen , C. A. 1967 . “The Human Pharmacology and Abuse Potential of N-allylnoroxy-morphone (Naloxone).” . J. Pharmacol. Exp. Ther. , Vol. 157 : 420 – 426 .
- Martin , W. R. , Gorodetzky , C. W. and McLane , T. K. 1966 . “An Experimental Study in the Treatment of Narcotic Addicts with Cyclazocine.” . Clin. Pharmacol. Ther. , Vol. 7 : 455 – 465 .
- Resnick , R. , Fink , M. and Freedman , A. M. 1970 . “A Cyclazocine Typology in Opiate Dependence.” . Amer. J. Psychiat. , Vol. 126 : 1256 – 1260 .
- Resnick , R. , Fink , M. and Freedman , A. M. 1971 . “Cyclazocine Therapy of Opiate Dependence-A Progress Report.” . Compr. Psychiat. , Vol. 12 : 491 – 502 .
- Sadove , M. S. , Balagot , R. C. , Hatano , S. and Jobgen , E. A. 1963 . “Study of a Narcotic Antagonist N-allylnoroxymorphone.” . J.A.M.A. , Vol. 183 : 666 – 668 .
- Wikler , A. 1965 . “Conditioning Factors in Opiate Addiction and Relapse.”. ” . In Narcotics. Edited by: Wilner , D. M. and Kassebaum , G. G. 85 – 100 . New York : McGraw-Hill Book Co. .
- Zaks , A. , Bruner , A. , Fink , M. and Freedman , A. M. 1969 . “Intravenous Diacetylmorphine (Heroin) in Studies of Opiate Dependence.” . Dis. Nerv. Syst. , Vol. 30 ( suppl. ) : 89 – 92 .
- Zaks , A. , Jones , T. , Fink , M. and Freedman , A. M. 1971 . “Naloxone Treatment of Opiate Dependence: A Progress Report.” . J.A.M.A. , Vol. 215 29 March : 2108 – 2110 .